Nizamettin TOPRAK

Kardiyoloji AD. Görüntüleme: 5336

erkekicon 

(Prof.Dr.) Kardiyoloji

ONLINE (GÖRÜNTÜLÜ) RANDEVU İÇİN TIKLAYINIZ! 

Kişisel Bilgiler

Akademik Personel Bilgileri

Adı

Nizamettin

Soyadı

TOPRAK

Ünvanı

Prof. Dr.

Doğum Yeri/Tarihi

Silvan

Üyesi Olduğu Dernekler

  

Birimi

Kardiyoloji           

Bölümü

Kardiyoloji           

E-posta

Bu e-Posta adresi istenmeyen posta engelleyicileri tarafından korunuyor. Görüntülemek için JavaScript etkinleştirilmelidir.

Yabancı Dil

İngilizce

Eğitim

LİSANS: Ege Üniversitesi Tıp Fakültesi

İHTİSAS:

Uzmanlık

  

İletişim

0412 248 80 01

Görevleri

  

{tab Özgeçmiş}

ÖZGEÇMİŞ

---

{tab Yayınlar}

YAYINLAR

                                             YAYINLAR VE ESERLER

  1. Ulgen MS, Ozturk O, Alan S, Kayrak M, Turan Y, Tekes S, Toprak N,  “The relationship between angiotensin-converting enzyme (insertion/deletion) gene polymorphism and left ventricular remodeling in acute myocardial infarction”, Coronary Artery Disease, 18(3): 153–157, 2007. AFTERLOAD REDUCING THERAPY
  2. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Abaci%20A&ut=000244821400009&pos=1">Abaci A, Kozan O, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Oguz%20A&ut=000244821400009&pos=3">Oguz A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Sahin%20M&ut=000244821400009&pos=4">Sahin M, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Deger%20N&ut=000244821400009&pos=5">Deger N, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Senocak%20H&ut=000244821400009&pos=6">Senocak H, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000244821400009&pos=7">Toprak N, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Sur%20H&ut=000244821400009&pos=8">Sur H, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Erol%20C&ut=000244821400009&pos=9">Erol C, “Prescribing pattern of antihypertensive drugs in primary care units in Turkey: results from the TURKSAHA study”, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 63(4): 397-402, 2007. HIGH BLOOD-PRESSURE

3.      SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Iltumur%20K&ut=000244047600025&pos=1">Iltumur K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Apak%20I&ut=000244047600025&pos=2">Apak I, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Aluclu%20U&ut=000244047600025&pos=3">Aluclu U, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ariturk%20Z&ut=000244047600025&pos=4">Ariturk Z, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000244047600025&pos=5">Toprak N, “Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke (vol 151, pg 1115, 2006)”, AMERICAN HEART JOURNAL, 153(2): 312-312, 2007. (CORRECTION)

  1. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Iltumur%20K&ut=000237638200038&pos=1">Iltumur K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karabulut%20A&ut=000237638200038&pos=2">Karabulut A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Apak%20I&ut=000237638200038&pos=3">Apak I, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Aluclu%20U&ut=000237638200038&pos=4">Aluclu U, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ariturk%20Z&ut=000237638200038&pos=5">Ariturk Z, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000237638200038&pos=6">Toprak N, “Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke”, AMERICAN HEART JOURNAL, 151(5): 1115-1122, 2006. HEART-FAILURE
  2. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Abaci%20A&ut=000236957500008&pos=1">Abaci A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Oguz%20A&ut=000236957500008&pos=2">Oguz A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Kozan%20O&ut=000236957500008&pos=3">Kozan O, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000236957500008&pos=4">Toprak N, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Senocak%20H&ut=000236957500008&pos=5">Senocak H, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Deger%20N&ut=000236957500008&pos=6">Deger N, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Sahin%20M&ut=000236957500008&pos=7">Sahin M, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Sur%20H&ut=000236957500008&pos=8">Sur H, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Fici%20F&ut=000236957500008&pos=9">Fici F, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Erol%20C&ut=000236957500008&pos=10">Erol C, “Treatment and control of hypertension in Turkish population: a survey on high blood pressure in primary care (the TURKSAHA study)”, JOURNAL OF HUMAN HYPERTENSION,     20(5): 355-361, 2006. hypertension in Turkish population
  3. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karabulut%20A&ut=000236242800002&pos=1">Karabulut A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Iltumur%20K&ut=000236242800002&pos=2">Iltumur K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Yalcin%20K&ut=000236242800002&pos=3">Yalcin K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000236242800002&pos=4">Toprak N, “Hepatopulmonary syndrome and right ventricular diastolic functions: An echocardiographic examination”, ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES,     23(4): 271-278, 2006. LIVER-CIRRHOSIS
  4. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karabulut%20A&ut=000234085000010&pos=1">Karabulut A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Kaplan%20A&ut=000234085000010&pos=2">Kaplan A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Aslan%20C&ut=000234085000010&pos=3">Aslan C, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Iltumur%20K&ut=000234085000010&pos=4">Iltumur K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20G&ut=000234085000010&pos=5">Toprak G, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000234085000010&pos=6">Toprak N, “The association between NT-proBNP levels, functional capacity and stage in patients with heart failure”, ACTA CARDIOLOGICA,   60(6): 631-638, 2005. NT-proBNP
  5. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Iltumur%20K&ut=000233497200007&pos=1">Iltumur K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karabulut%20A&ut=000233497200007&pos=2">Karabulut A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Yokus%20B&ut=000233497200007&pos=3">Yokus B, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Yavuzkir%20M&ut=000233497200007&pos=4">Yavuzkir M, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Taskesen%20T&ut=000233497200007&pos=5">Taskesen T, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000233497200007&pos=6">Toprak N, “N-terminal proBNP plasma levels correlate with severity of mitral stenosis”, JOURNAL OF HEART VALVE DISEASE,   14(6): 735-741, 2005. BRAIN NATRIURETIC PEPTIDE
  6. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Iltumur%20K&ut=000233987104287&pos=1">Iltumur K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karabulut%20A&ut=000233987104287&pos=2">Karabulut A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karadede%20A&ut=000233987104287&pos=3">Karadede A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000233987104287&pos=4">Toprak N, “Atrial volume changes in anterior myocardial infarction”, EUROPEAN HEART JOURNAL,   26:604-605,    Supplement: Suppl. 1, 2005 (MEETING ABSTRACT)
  7. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karabulut%20A&ut=000233880500001&pos=1">Karabulut A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Iltumur%20K&ut=000233880500001&pos=2">Iltumur K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000233880500001&pos=3">Toprak N, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Tuzcu%20AK&ut=000233880500001&pos=4">Tuzcu AK, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Kara%20IH&ut=000233880500001&pos=5">Kara IH, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Kaplan%20A&ut=000233880500001&pos=6">Kaplan A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Aksu%20Y&ut=000233880500001&pos=7">Aksu Y, “Insulin response to oral glucose loading and coronary artery disease in nondiabetics”,  INTERNATIONAL HEART JOURNAL, 46(5): 761-770, 2005. TYPE-2 DIABETES-MELLITUS-HEART-DISEASE
  8. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Iltumur%20K&ut=000232082400022&pos=1">Iltumur K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karabulut%20A&ut=000232082400022&pos=2">Karabulut A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karadede%20A&ut=000232082400022&pos=3">Karadede A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000232082400022&pos=4">Toprak N, “Iatrogenic left atrioventricular fistula after aortic valve re-replacement”, JOURNAL OF HEART VALVE DISEASE,  14(5): 697-699, 2005. RIGHT ATRIAL FISTULA
  9. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Iltumur%20K&ut=000232151500018&pos=1">Iltumur K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Olmez%20G&ut=000232151500018&pos=2">Olmez G, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ariturk%20Z&ut=000232151500018&pos=3">Ariturk Z, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Taskesen%20T&ut=000232151500018&pos=4">Taskesen T, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000232151500018&pos=5">Toprak N, “Clinical investigation: Thyroid function test abnormalities in cardiac arrest associated with acute coronary syndrome”, CRITICAL CARE , 9(4): R416-R424, 2005. ACUTE MYOCARDIAL-INFARCTION
  10. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Iltumur%20K&ut=000228216000003&pos=1">Iltumur K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karabulut%20A&ut=000228216000003&pos=2">Karabulut A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20G&ut=000228216000003&pos=3">Toprak G, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000228216000003&pos=4">Toprak NComplement activation in acute coronary syndromes, APMIS    Volume: 113    Issue: 3    Pages: 167-174    Published: MAR 2005, C-REACTIVE PROTEIN
  11. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ozturk%20O&ut=000226647900015&pos=1">Ozturk O, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000226647900015&pos=2">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Tekes%20S&ut=000226647900015&pos=3">Tekes S, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ozturk%20U&ut=000226647900015&pos=4">Ozturk U, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000226647900015&pos=5">Toprak N, “Influence of angiotensin-converting enzyme I/D gene polymorphism on the right ventricular myocardial performance index in patients with a first acute anterior myocardial infarction”,  CIRCULATION JOURNAL, 69(2): 211-215, 2005. INSERTION DELETION POLYMORPHISM
  12. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Iltumar%20K&ut=000224783502587&pos=1">Iltumar K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karabulut%20A&ut=000224783502587&pos=2">Karabulut A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000224783502587&pos=3">Toprak N, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Diyarbakir%20ESC&ut=000224783502587&pos=4">Diyarbakir ESC, “N-terminal pro-brain natriuretic pepticle in patients with acute ischemic stroke”, CIRCULATION, 110(17): 483-483,    Supplement: Suppl. S, 2004. (MEETING ABSTRACT)
  13. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ozturk%20O&ut=000224056502402&pos=1">Ozturk O, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000224056502402&pos=2">Toprak N, “Effect of the angiotensin-ii type 1 receptor gene polymorphisms on left ventricular remodeling in patients with a first acute anterior myocardial infarction”, EUROPEAN HEART JOURNAL, 25: 598-598,    Supplement: Suppl. S, 2004. (MEETING ABSTRACT)
  14. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Alan%20S&ut=000222618600008&pos=1">Alan S, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000222618600008&pos=2">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Akdeniz%20S&ut=000222618600008&pos=3">Akdeniz S, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Alan%20B&ut=000222618600008&pos=4">Alan B, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000222618600008&pos=5">Toprak N, “Intima-media thickness and arterial distensibility in Behcet's disease”, ANGIOLOGY, 55(4): 413-419, 2004. ASCENDING AORTA
  15. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Alan%20S&ut=000188084600011&pos=1">Alan S, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000188084600011&pos=2">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Soker%20M&ut=000188084600011&pos=3">Soker M, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Geyik%20F&ut=000188084600011&pos=4">Geyik F, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karabulut%20A&ut=000188084600011&pos=5">Karabulut A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000188084600011&pos=6">Toprak N, “Electrocardiologic and echocardiographic features of patients exposed to scorpion bite”, ANGIOLOGY, 55(1): 79-84, 2004. ACUTE MYOCARDIAL-INFARCTION, HEART-RATE-VARIABILITY
  16. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Alan%20S&ut=000185949600003&pos=1">Alan S, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000185949600003&pos=2">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Dedeoglu%20I&ut=000185949600003&pos=3">Dedeoglu I, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Kaya%20H&ut=000185949600003&pos=4">Kaya H, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000185949600003&pos=5">Toprak N, “Long-term glucose insulin potassium infusion improves systolic and diastolic function in patients with chronic ischaemic cardiomyopathy”, SWISS MEDICAL WEEKLY, 133(29-30): 419-422, 2003. ischaemic cardiomyopathy
  17. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Alan%20S&ut=000182920800001&pos=1">Alan S, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000182920800001&pos=2">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ozturk%20O&ut=000182920800001&pos=3">Ozturk O, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Alan%20B&ut=000182920800001&pos=4">Alan B, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ozdemir%20L&ut=000182920800001&pos=5">Ozdemir L, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000182920800001&pos=6">Toprak N, “Relation between coronary artery disease, risk factors and intima-media thickness of carotid artery, arterial distensibility, and stiffness index”, ANGIOLOGY, 54(3):261-267, 2003. HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
  18. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Alan%20S&ut=000178261400012&pos=1">Alan S, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000178261400012&pos=2">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ozdemir%20K&ut=000178261400012&pos=3">Ozdemir K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Keles%20T&ut=000178261400012&pos=4">Keles T, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000178261400012&pos=5">Toprak N, “Reliability and efficacy of metoprolol and diltiazem in patients having mild to moderate mitral stenosis with sinus rhythm”, ANGIOLOGY, 53(5): 575-581, 2002. ATENOLOL
  19. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karadede%20A&ut=000175472000004&pos=1">Karadede A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Aydinalp%20O&ut=000175472000004&pos=2">Aydinalp O, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Temamogullari%20AV&ut=000175472000004&pos=3">Temamogullari AV, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000175472000004&pos=4">Toprak N, “The relationship of ST segment elevation shape with preserved myocardium and signal-averaged electrocardiography in acute anterior myocardial infarction”, HEART AND VESSELS, 16(4) 146-153, 2002. ST segment
  20. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000171572500007&pos=1">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karadede%20A&ut=000171572500007&pos=2">Karadede A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Alan%20S&ut=000171572500007&pos=3">Alan S, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000171572500007&pos=4">Toprak N, “The value of hemodynamic changes induced by carotid sinus massage on the diagnosis of coronary artery disease”, ANGIOLOGY, 52(10): 703-709, 2001. SYNCOPE; HYPERSENSITIVITY; ANGIOGRAPHY
  21. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000171027800003&pos=1">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000171027800003&pos=2">Toprak N, “The effects of right ventricular involvement on heart rate variability and ventricular late potentials in acute inferior myocardial infarction”, ANGIOLOGY, 52(9):597-603, 2001. SIGNAL-AVERAGED ELECTROCARDIOGRAM
  22. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000171509800010&pos=1">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Alan%20S&ut=000171509800010&pos=2">Alan S, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Akdemir%20O&ut=000171509800010&pos=3">Akdemir O, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000171509800010&pos=4">Toprak N, “The effect of glucose-insulin-potassium solution on ventricular late potentials and heart rate variability in acute myocardial infarction”, CORONARY ARTERY DISEASE, 12(6): 507–512, 2001. SIGNAL-AVERAGED ELECTROCARDIOGRAM
  23. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karadede%20A&ut=000170988301245&pos=1">Karadede A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Aydynalp%20O&ut=000170988301245&pos=2">Aydynalp O, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Temamogullary%20A&ut=000170988301245&pos=3">Temamogullary A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000170988301245&pos=4">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Sucu%20M&ut=000170988301245&pos=5">Sucu M, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000170988301245&pos=6">Toprak N, “The relation between ST-segment elevation shape and both of signal-averaged EKG and clinical course in early period of anterior myocardial infarction”, EUROPEAN HEART JOURNAL, 22: 326-326, Suppl. S, 2001. (MEETING ABSTRACT)
  24. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000169511600011&pos=1">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Bilici%20A&ut=000169511600011&pos=2">Bilici A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Acar%20M&ut=000169511600011&pos=3">Acar M, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000169511600011&pos=4">Toprak N, “The relationship of coronary artery disease and carotid Doppler flow velocity and resistance index in patients with no significant carotid stenosis”, ANGIOLOGY, 52(6):433-434, 2001. ATHEROSCLEROSIS
  25. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000167395000020&pos=1">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Akdemir%20O&ut=000167395000020&pos=2">Akdemir O, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000167395000020&pos=3">Toprak N, “The effects of trimetazidine on heart rate variability and signal-averaged electrocardiography in early period of acute myocardial infarction”, INTERNATIONAL JOURNAL OF CARDIOLOGY, 77(2-3): 255-262, 2001. trimetazidine; HRV; VLP; AMI
  26. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000166901600003&pos=1">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karadede%20A&ut=000166901600003&pos=2">Karadede A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Alan%20S&ut=000166901600003&pos=3">Alan S, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Temamogulari%20AV&ut=000166901600003&pos=4">Temamogulari AV, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karabulut%20A&ut=000166901600003&pos=5">Karabulut A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000166901600003&pos=6">Toprak N, “Contribution of the peak exercise QT dispersion to the accuracy of an exercise test during the evaluation of coronary artery disease”, ACTA CARDIOLOGICA, 55(6): 335-339, 2000. exercise test; QT dispersion; coronary artery disease
  27. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000170455500007&pos=1">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Alan%20S&ut=000170455500007&pos=2">Alan S, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karadede%20A&ut=000170455500007&pos=3">Karadede A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Aydinalp%20O&ut=000170455500007&pos=4">Aydinalp O, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000170455500007&pos=5">Toprak N, “Cardiac hydatid cysts located in both the left ventricular apex and the intraventricular septum: Case report”, HEART AND VESSELS, 15(5): 243-244, 2000. cardiac hydatid cyst
  28. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000089136601718&pos=1">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Alan%20S&ut=000089136601718&pos=2">Alan S, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karadede%20A&ut=000089136601718&pos=3">Karadede A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Iltimur%20K&ut=000089136601718&pos=4">Iltimur K, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000089136601718&pos=5">Toprak N, “The effects of glucose-insulin-potassium therapy on signal-averaged electro-cardiography and heart rate variability in acute myocardial infarction”, EUROPEAN HEART JOURNAL, 21: 442-442, Suppl. S, 2000. (MEETING ABSTRACT)
  29. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karadede%20A&ut=000088270300012&pos=1">Karadede A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000088270300012&pos=2">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Temamogullari%20AV&ut=000088270300012&pos=3">Temamogullari AV, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000088270300012&pos=4">Toprak N, “A complicated case of pericardial hydatid cyst manifesting as constrictive pericarditis”, CANADIAN JOURNAL OF CARDIOLOGY, 16(5): 673-676, 2000. lesion; pericarditis
  30. SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Ulgen%20MS&ut=000083924100003&pos=1">Ulgen MS, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Biyik%20I&ut=000083924100003&pos=2">Biyik I, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Karadede%20A&ut=000083924100003&pos=3">Karadede A, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Temamogullari%20AV&ut=000083924100003&pos=4">Temamogullari AV, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Alan%20S&ut=000083924100003&pos=5">Alan S, SID=W1L1Ppcd2pg1bHCgb@c&field=AU&;;value=Toprak%20N&ut=000083924100003&pos=6">Toprak N, “Relation between QT dispersion and ventricular arrhythmias in uncomplicated isolated mitral valve prolapse”, APANESE CIRCULATION JOURNAL-ENGLISH EDITION, 63(12): 929-933, 1999. SUDDEN-DEATH

 

{/tabs}

Pin It

Misyon ve Vizyonumuz

MİSYONUMUZ
Hasta, hasta yakını ve çalışan odaklı, çağdaş tıbbi etik ilkelerini benimseyen, Sağlıkta Kalite, Akreditasyon, Verimlilik, Mükemmellik ve Yönetim sistemleri standartlarına uygun ve katılımcı yönetim anlayışı ile bütüncül bir sağlık hizmeti sunmaktır.
VİZYONUMUZ
"Halka Hizmet, Hakka Hizmettir" anlayışıyla, Sağlıkta Kalite, Akreditasyon, Verimlilik, Mükemmellik ve Yönetim sistemleri standartları çerçevesinde, sürekli bilgi ve teknolojisini yenileyebilen, Ülkemizde ve komşu ülkelerde güvenle anılan bir referans hastane olmaktır.

Temel Değerlerimiz

• Hasta, Hasta Yakını ve Çalışan Önceliği,
• Çalışanların aidiyet duygusu, dayanışması ve motivasyonu,
• Eğitim ve Gelişimde Süreklilik,
• Ölçümlere Dayalı Hizmet Planlaması ve Üretimi,
• Kaynakların Etkin Kullanımı,
• Önyargısız Yaklaşım, kalıcı güven
• Bilimsel ve Etik Kurallar,
• Katılımcılık, etkinlik ve etkililik.

İletişim

  • Adres: Dicle Üniversitesi Tıp Fakültesi Hastaneleri
    Başhekimliği, Kampüs, Sur, Diyarbakır, Türkiye 21280
  • Randevu: 0850 480 21 21
  • Santral: 0850 480 21 00
  • Faks: 0 412 248 85 23
  • E-Posta: hastane@dicle.edu.tr
Free Joomla! templates by Engine Templates